Publications and communications of Laurence LUTTERI

El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435

Castiglione, V., Berodes, M., LUKAS, P., Louis, E., Cavalier, E., & Lutteri, L. (27 September 2022). New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method. Diagnostics, 12 (10), 2338. doi:10.3390/diagnostics12102338

El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006

Lambert, N., LUTTERI, L., TSHIBANDA, L., BIANCHI, E., & MAQUET, P. (2022). Anti-SOX1 antibody-associated acute hemorrhagic leukoencephalitis. Journal of Neurology. doi:10.1007/s00415-022-10984-5

Dauby, S., DIVE, D., LUTTERI, L., ANDRIS, C., HANSEN, I., MAQUET, P., & LOMMERS, E. (2022). Comparative study of AQP4‑NMOSD, MOGAD and seronegative NMOSD: a single‑center Belgian cohort. Acta Neurologica Belgica. doi:10.1007/s13760-021-01712-3

Desmecht, S.* , Tashkeev, A.* , El Moussaoui, M., MARECHAL, N., Perée, H., Tokunaga, Y., Fombellida-Lopez, C., Polese, B., Legrand, C., Wéry, M., Mni, M., Fouillien, N., TOUSSAINT, F., Gillet, L., Bureau, F., LUTTERI, L., HAYETTE, M.-P., MOUTSCHEN, M., MEURIS, C., ... DARCIS, G.*. (2022). Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and -experienced subjects: impact of booster dose and breakthrough infections. Frontiers in Immunology, 13, 863554. doi:10.3389/fimmu.2022.863554

CASTIGLIONE, V., CAVALIER, E., LUTTERI, L., LUKAS, P., & BERODES, M. (19 November 2021). NEW FAECAL CALPROTECTIN ASSAY BY IDS: VALIDATION AND COMPARISON TO DIASORIN METHOD [Paper presentation]. RBSLM Annual Meeting, Brussels, Belgium.

Lambert, N., LUTTERI, L., SADZOT, B., MAQUET, P., & Moonen, G. (June 2021). Les syndromes neurologiques paranéoplasiques. Revue Médicale de Liège, 76 (5-6), 413-418.

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1

RADERMECKER, A., BONNET, C., LUTTERI, L., CHAPELLE, A.-C., PETIGNOT, S., LIEVENS, I., & CAERS, J. (2021). Un cas illustratif de syndrome de POEMS. Revue Médicale de Liège, 76, 156-159.

LUTTERI, L. (22 November 2019). ANA pattern harmonization: where are we? [Paper presentation]. Congrès Sciensano, Antwerpen, Belgium.

LUTTERI, L., CARLISI, I., STOJKOVIC, V., & CAVALIER, E. (15 November 2019). WHEN THE REFERENCE VALUES OF APOLIPOPROTEINS A AND B HAVE TO BE REVIEWED… [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

LUTTERI, L., CARLISI, I., STOJKOVIC, V., & CAVALIER, E. (15 November 2019). Evaluation of inflammatory proteins tests using Optilite Analyzer [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (15 November 2019). One year of follow-up of the index for negative/positive discrimination of ANA detection on G-Sight microscope [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (15 November 2019). Evaluation of Quantiferon TB Gold Plus Test Using Liaison XL Analyzer [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (15 November 2019). Evaluation of free light chains Elisa test using AP22 Elite instrument and comparison with freelite test on SPA plus [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

LUTTERI, L. (24 October 2019). Games of Crohn : la revanche de l’auto-immunité [Paper presentation]. Congrès Menarini, Liège, Belgium.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (June 2019). Evaluation of the Sebia free light chains ELISA using the AP22 Elite instrument [Poster presentation]. Euromedlab, Barcelone, Spain.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (June 2019). Evaluation of Diasorin Quantiferon-TB Gold Plus test using Liaison XL [Poster presentation]. Euromedlab, Barcelone, Spain.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (June 2019). Evaluation and perspectives of the index for negative/positive discrimination of ANA detection on G-Sight microscope [Poster presentation]. Euromedlab, Barcelone, Spain.

LUTTERI, L. (16 May 2019). Liaison Quantiferon TB Gold Plus : customer experience [Paper presentation]. Congrès Diasorin, Turin, Italy.

Broeders, S., Goletti, S., Tomasi, J.-P., Bonroy, C., Humbel, R.-L., Lutteri, L., Schouwers, S., Van Hoovels, L., Vercammen, M., & Bossuyt, X. (2019). Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment. Annals of the Rheumatic Diseases. doi:10.1136/annrheumdis-2018-214078

STOJKOVIC, V., Delanaye, P., COLLARD, G., FERRANTE, N., Le Goff, C., Lutteri, L., & Cavalier, E. (2019). Estimated glomerular filtration rate using a point of care measure of creatinine in patients with iohexol determinate GFR. Clinica Chimica Acta, 499, 123-127. doi:10.1016/j.cca.2019.08.032

Résimont, G., GADISSEUR, R., LUTTERI, L., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (October 2018). Comment j'explore...Une protéinurie. Revue Médicale de Liège, 73 (10), 519-525.

NECHIFOR, I., JONAS, C., LUTTERI, L., Beckers, A., & PINTIAUX, A. (2018). Fluctuating primary ovarian insufficiency in a case of type 2 autoimmune polyendocrinopathy. In Abstract book : Gynecological endocrinology the 18th world congress.

Gonzalez-Aguilera, B., BETEA, D., LUTTERI, L., CAVALIER, E., GEENEN, V., Beckers, A., & VALDES SOCIN, H. G. (2018). Conversion to Graves disease from Hashimoto thyroiditis : a study of 24 patients. Archives of Endocrinology and Metabolism. doi:10.20945/2359-3997000000086

Lutteri, L., ALDENHOFF, M.-C., & Cavalier, E. (2018). Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument. Clinica Chimica Acta, 487, 161-167. doi:10.1016/j.cca.2018.09.030

Lutteri, L., & Jacobs, J. F. M. (2018). Reference ranges of the Sebia free light chain ratio in patients with chronic kidney disease. Clinical Chemistry and Laboratory Medicine, 56 (9), 232-e234. doi:10.1515/cclm-2018-0040

Pirotte, M.* , Forte, F.* , Lutteri, L., WILLEMS, E., DURAN, U., Belle, L., Baron, F., BEGUIN, Y., Maquet, P., BODART, O.* , & Servais, S.*. (2018). Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Journal of Neuroimmunology, 323, 115-118. doi:10.1016/j.jneuroim.2018.08.003

KREUTZ, J., Potorac, I., LUTTERI, L., GENNIGENS, C., MARTIN, D., Daly, A., BONNEVILLE, J.-F., TSHIBANDA, L., & BECKERS, A. (2017). Adipsic diabetes insipidus revealing a bifocal intracranial germinoma. Annales d'Endocrinologie. doi:10.1016/j.ando.2016.10.005

LUTTERI, L. (29 January 2016). Un laboratoire d'auto-immunité paperless: mythe ou réalité? [Paper presentation]. Focus Conference, Bruxelles, Belgium.

LUTTERI, L., Dierge, L., PESSER, M., WATRIN, P., & Cavalier, E. (2016). A paperless autoimmunity laboratory: myth or reality? Annales de Biologie Clinique, 74 (4), 477-89. doi:10.1684/abc.2016.1164

VALDES SOCIN, H. G., SID, S., LUTTERI, L., POLUS, M., Louis, E., Beguin, Y., & Beckers, A. (2016). Le syndrome thyro-gastrique auto-immun : actualités cliniques et thérapeutiques. Vaisseaux, Coeur, Poumons, 21 (4), 40-45.

Sid, S., LUTTERI, L., BEGUIN, Y., Louis, E., Beckers, A., & VALDES SOCIN, H. G. (2015). Familial thyrogastric autoimmune syndrome : a study of 22 kindreds. In Abstract book - 20th Annual Congress of the Belgian Society of Internal Medicine.

LUTTERI, L., CAVALIER, E., & ALDENHOFF, M.-C. (14 November 2015). CALPROTECTIN IN STOOL: COMPARISON BETWEEN ELISA AND CHEMILUMINESCENT IMMUNOASSAY [Poster presentation]. Congrès annuel SRBML, Bruxelles, Belgium.

LUTTERI, L. (29 October 2015). Recherche des auto-anticorps dans les pathologies auto-immunes hépatiques [Paper presentation]. Settings Standards for the future, Bruxelles, Belgium.

VALDES SOCIN, H. G., MESUREUR, T., POLUS, M., DELWAIDE, J., Louis, E., LUTTERI, L., & Beckers, A. (2015). Syndrome thyrogastrique autoimmun (STGA) : la gastrite auto-immune isolée (GAI) et celle associée à Helicobacter (Hp) ont des caractéristiques anatomocliniques différentes. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

LUTTERI, L. (24 September 2015). Test au quantiferon dans le diagnostic de la tuberculose [Paper presentation]. Congrès Corata, Beaune, France.

LUTTERI, L. (18 June 2015). Les anti-TNFalpha, leurs dosages et usages en gastroentérologie [Paper presentation]. Formations continues en biologie clinique, Liège, Belgium.

LUTTERI, L. (23 April 2015). Les anticorps anti-nucléaires : stratégies de recherche et nouveautés cliniques en 2015 [Paper presentation]. Formations continues en biologie clinique, Liège, Belgium.

LUTTERI, L., CAVALIER, E., & Frenay, S. (16 April 2015). IS IT POSSIBLE TO MONITOR MONOCLONAL GAMMOPATHY WITH N LATEX FLC (SIEMENS) AS WELL AS FREELITE? [Poster presentation]. 7ème congrès international : Clinical applications of free light chain and heavy chain analysis, Edinburgh, United Kingdom.

DE SENY, D., COBRAIVILLE, G., CHARLIER, E., NEUVILLE, S., LUTTERI, L., LE GOFF, C., MALAISE, D., MALAISE, O., CHAPELLE, J.-P., RELIC, B., & MALAISE, M. (2015). Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory properties. PLoS ONE. doi:10.1371/journal.pone.0122904

LUTTERI, L. (07 March 2015). Les anticorps anti-nucléaires [Paper presentation]. RAIL, Liège, Belgium.

MALAISE, O., JACQUERIE, P., Halleux, S., LUTTERI, L., VON FRENCKELL, C., & Malaise, M. (December 2014). Co-existence des anticorps anti-ADN double brin et des anticorps anti-peptides citrullinés: entre lupus médicamenteux induit et rhupus [Poster presentation]. Congrès de la Société Française de Rhumatologie 2014.

LUTTERI, L. (October 2014). Un laboratoire d’autoimmunité paperless : mythe ou réalité ? [Paper presentation]. Congrès Corata, Reims, France.

LUTTERI, L. (18 September 2014). Tests de laboratoire en immunogénicité [Paper presentation]. Immunogénicité et biothérapie : relevance clinique en dermatologie, Liège, Belgium.

LUTTERI, L., PESSER, M., WATRIN, P., & CAVALIER, E. (March 2014). ANTI-NUCLEAR ANTIBODIES : PREVALENCE OF DIFFERENT PATTERNS AND ANTIBODIES IN A BELGIAN UNIVERSITY LABORATORY [Poster presentation]. 9ème congrès international d’auto-immunité, Nice, France.

LUTTERI, L., PESSER, M., WATRIN, P., & CAVALIER, E. (March 2014). A PAPERLESS AUTOIMMUNITY LABORATORY : IS IT POSSIBLE ? [Poster presentation]. 9ème congrès international d’auto-immunité.

Sepulchre, E., LUTTERI, L., CAVALIER, E., Guerci, B., & RADERMECKER, R. (2014). A propos de l'hémoglobine glyquée: Les limites de son interprétation. Revue Médicale de Liège, 69 (9), 497-503.

VALDES SOCIN, H. G., LUTTERI, L., Cavalier, E., POLUS, M., Geenen, V., Louis, E., & Beckers, A. (2014). El sindrome tirogastrico autoinmune : sus efectos sobre los micronutrientes y la tumorigenesis gastrica. Revista Argentina de Endocrinologia y Metabolismo, 51, 37-43.

VALDES SOCIN, H. G., Tudorescu, A., LUTTERI, L., Geenen, V., & Beckers, A. (October 2013). Hypothyroïdie infraclinique non auto-immune et statut iodé : étude prospective d'intervention. Annales d'Endocrinologie, 74, 352.

DELANAYE, P., Bruyère, O., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & CAVALIER, E. (May 2013). Creatinine-or cystatin C-based equations to estimate glomerular filtration: impact on the epidemiology of chronic kidney disease [Poster presentation]. 20th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab), Milan, Italy.

DELANAYE, P., Cavalier, E., Moranne, O., Bruyère, O., LUTTERI, L., & Krzesinski, J.-M. (May 2013). Creatinine- or cystatin C-based equations to estimate glomerular filtration rate in the general population: impact on the epidemiology of chronic kidney disease [Poster presentation]. 50th ERA-EDTA Congress, Istanbul, Turkey.

Dierge, L., LUTTERI, L., Chauvet, D., Hastir, D., CHAPELLE, J.-P., & CAVALIER, E. (May 2013). Heavy/light chain (HLC) and free light chain (FLC) analysis allow sensitive monitoring of multiple myeloma patients and AID detection of clonal changes. Biochimica Clinica, 37 (SS), 618.

DELANAYE, P., CAVALIER, E., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & Bruyère, O. (12 March 2013). Creatinine - or cystatin C - based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrology, 14, 57. doi:10.1186/1471-2369-14-57

VALDES SOCIN, H. G., LUTTERI, L., CAVALIER, E., POLUS, M., LOUIS, E., & BECKERS, A. (2013). le syndrome auto-immun thyrogastrique: ses effets sur les micronutriments et la tumorigénèse gastrique. Revue Médicale de Liège.

MALAISE, O., HALLEUX, S., VON FRENCKELL, C., LUTTERI, L., CHAPELLE, J.-P., & Malaise, M. (September 2012). Rhupus: when rheumatoid arthritis meets lupus. Revue Médicale de Liège, 67 (9), 475-84.

VALDES SOCIN, H. G., LOLY, J., GAST, P., LUTTERI, L., VRANKEN, L., Cavalier, E., & Beckers, A. (2012). The thyrogastric syndrome : an under diagnosed etiology for acquired gastric neuroendocrine tumors. A case report. In Abstract Book - 13th International Workshop on Multiple Endocrine Neoplasia.

HAMDI, E., DELANAYE, P., LUTTERI, L., CHAPELLE, J.-P., & CAVALIER, E. (18 July 2012). analytical and Clinical Validation of Beta-Trace Protein, a New Marker of Glomerular Filtration Rate [Poster presentation]. AACC 2012, Los Angeles, United States.

HAMDI, E., HALENG, J., LUTTERI, L., & CHAPELLE, J.-P. (2012). Influence of free kappa light chains in urine on total urinary protein: Results obtained by turbidimetry (MODULAR P800) and colorimetry (VITROS 350) [Poster presentation]. 29ème Colloque CORATA-BIOCLINORD, LILLE.

VALDES SOCIN, H. G., TOME, M., LUTTERI, L., Reenaers, C., POLUS, M., Geenen, V., LOUIS, E., & Beckers, A. (2012). Auto-immune gastritis characteristics in a large series of patients with auto-immune thyroiditis. In XXIVth Belgian Week of Gastroenterology 2012 - Abstract book.

Kaux, J.-F., Le Goff, C., Renouf, J., Lutteri, L., Peters, P., Gothot, A., & Crielaard, J.-M. (October 2011). Comparison of the platelet concentrations obtained in platelet-rich plasma (PRP) between the GPS™ II and GPS™ III systems. Pathologie Biologie, 59 (5), 275-277. doi:10.1016/j.patbio.2010.11.002

VALDES SOCIN, H. G., & LUTTERI, L. (October 2011). Le syndrome thyrogastrique: de l'autoimmunité gastrique aux néoplasies neuroendocriniennes de l'estomac [Paper presentation]. GLEM Endocrinologie, Liège - Herstall-, Belgium.

TOME GARCIA, M., VALDES SOCIN, H. G., LUTTERI, L., BETEA, D., VROONEN, L., PETROSSIANS, P., Geenen, V., Louis, E., & Beckers, A. (2011). The Thyro-gastric syndrome : its prevalence, clinical, pathological and predictive factors in a prospective series of 360 patients with Hashimoto's Thyroiditis. In Abstract book - 21st Meeting of the Belgian Endocrine Society.

VALDES SOCIN, H. G., Tome, M., LUTTERI, L., Louis, E., & Beckers, A. (2011). Prevalence and prediction of gastric mucosal abnormalities in a prospective series of 50 patients with graves-Basedow disease [Poster presentation]. Belgian Internal Medicine Society, Bruxelles, Belgium.

Valdes Socin, H. G., Lutteri, L., Latta, A., Vroonen, L., Betea, D., Petrossians, P., Geenen, V., & Beckers, A. (September 2010). Prévalence de gastrite auto-immune et études histologiques dans une série prospective de 240 patients avec thyroïdite de Hashimoto. Annales d'Endocrinologie, 71 (5), 416-417.

Valdes Socin, H. G., Lutteri, L., Latta, A., Vroonen, L., Betea, D., Petrossians, P., Geenen, V., & Beckers, A. (2010). Hypergastrinemia, parietal cell antibodies and vitamine B12 deficiency in a prospective series of 240 patients with autoimmune thyroiditis: from autoimmune gastritis to enterochomafi n cells hyperplasia. In European Neuroendocrine Association - Liège, 22-25 septembre 2010.

Valdes Socin, H. G., Lutteri, L., Latta, K., Vroonen, L., Betea, D., Petrossians, P., Geenen, V., & Beckers, A. (2010). Hypergastrinemia, parietal cell antibodies and vitamine B12 deficiency in a prospective series of 240 patients with autoimmune thyroiditis : from autoimmune gastritis to enterochomafin celles hyperplasia. In European Neuroendocrine Association - Liège, 22-25 septembre 2010.

Kaux, J.-F., Le Goff, C., Renouf, J., Peters, P., Lutteri, L., Gothot, A., & Crielaard, J.-M. (20 March 2010). GPS™ II and GPS™ III: comparison of obtained platelets concentrations [Poster presentation]. VVS Biennial Congress for Sports Medicine and Sports Sciences, Brugge, Belgium.

Lutteri, L., Sagot, L., & Chapelle, J.-P. (March 2010). Anticorps anti-gliadines déamidées et maladie coeliaque : données actuelles et évaluation des faux positifs de cinq trousses de dosage. Annales de Biologie Clinique, 68 (2), 149-56. doi:10.1684/abc.2010.0398

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., & Krzesinski, J.-M. (2009). Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scandinavian Journal of Clinical and Laboratory Investigation, 69 (3), 344-9. doi:10.1080/00365510802609856

Mistretta, V., Cavalier, E., Collette, J., Lutteri, L., & Chapelle, J.-P. (2009). Intérêt des anticorps monoclonaux dans le laboratoire d'analyses biomédicales. Revue Médicale de Liège, 64 (5-6), 257-263.

Cavalier, E., Péroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (November 2008). Etude analytique des trois trousses de cystatine C et impact sur les formules basées sur la cystatine pour l'estimation du DFG. Néphrologie et Thérapeutique, 4 (6), 399-400.

Lutteri, L., Le Goff, C., & Chapelle, J.-P. (May 2008). Very high performance of deamidated gliadin peptide antibodies in the diagnosis of coeliac disease [Poster presentation]. International Symposium "Brussels 2008" SBCC, Bruxellles, Belgium.

De Seny, D., Fillet, M., Ribbens, C., Marée, R., Meuwis, M.-A., Lutteri, L., Chapelle, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., & Malaise, M. (2008). Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clinical Chemistry, 54, 1066-1075. doi:10.1373/clinchem.2007.099549

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., Chapelle, J.-P., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale chronique par l’estimation du DFG avec une formule basée sur la créatinine versus la cystatine C [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Delanaye, P., Pieroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., Hainque, B., & Cavalier, E. (2008). Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clinica Chimica Acta, 398 (1-2), 118-24. doi:10.1016/j.cca.2008.09.001

Le Goff, C., Kaux, J.-F., Chapelle, J.-P., & Lutteri, L. (January 2008). Comment j'explore... Revue des principaux auto-anticorps. Revue Médicale de Liège, 63 (1), 43-9.

Meuwis, M.-A.* , Fillet, M.* , Lutteri, L., Marée, R., Geurts, P., De Seny, D., Malaise, M., Chapelle, J.-P., Wehenkel, L., Belaiche, J., Merville, M.-P., & Louis, E. (2008). Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clinical Biochemistry, 41 (12), 960-7. doi:10.1016/j.clinbiochem.2008.04.021

Piéroni, L., Delanaye, P., Abshoff, C., Lutteri, L., Chapelle, J.-P., Hainque, B., Krzesinski, J.-M., & Cavalier, E. (2008). Impact de la stabilité de la cystatine C sur la validité des mesures dans les études rétrospectives [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Le Goff, C., Chapelle, J.-P., & Lutteri, L. (November 2007). Comparaison de cinq techniques de détection des anticorps anti-saccharomyces cerevisae (ASCA) dans le sérum pour le diagnostic de la maladie de Crohn. Annales de Biologie Clinique, 65 (6), 601-608.

Le Goff, C., Chapelle, J.-P., & Lutteri, L. (October 2007). Comparison of first and second generation m2-ELISA in primary biliary cirrhosis'diagnosis [Poster presentation]. Symposium de la Société Belge de Biologie clinique, Bruxelles, ULB, Belgium.

Le Goff, C., Lutteri, L., & Chapelle, J.-P. (2007). Detection of ASCA and the diagnosis of crohn's disease [Poster presentation]. 17 IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands.

Lutteri, L., Malaise, M., & Chapelle, J.-P. (2007). Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. Clinica Chimica Acta, 386 (1-2), 76-81. doi:10.1016/j.cca.2007.08.002

Meuwis, M.-A.* , Fillet, M.* , Geurts, P., De Seny, D., Lutteri, L., Chapelle, J.-P., Bours, V., Wehenkel, L., Belaiche, J., Malaise, M., Louis, E., & Merville, M.-P. (2007). Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochemical Pharmacology, 73 (9), 1422-1433. doi:10.1016/j.bcp.2006.12.019

Le Goff, C., Lutteri, L., & Chapelle, J.-P. (16 March 2006). Les anticorps anti-saccharomyces cerevisiae: comment les rechercher? [Poster presentation]. EUROBIOLOGIE, Nancy, France.

Lutteri, L., Malaise, M., & Chapelle, J.-P. (27 October 2005). Evaluation of the new Elisa CCp assay on unicap 100 [Poster presentation]. Annual Symposium of the Belgian Societies of Clinical Chemistry and Clinical Biology, Liège, Belgium.

De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607

Lutteri, L., Malaise, M., & Chapelle, J.-P. (09 October 2004). In rheumatoid arthritis, anti-citrullinated peptides antibodies are concentrated in synovial fluid [Poster presentation]. Symposium de la Société Belge de Biologie Clinique, Belgium.

De Seny, D., Fillet, M., Meuwis, M.-A., Lutteri, L., Geurts, P., Wehenkel, L., Bours, V., Piette, J., Malaise, M., & Merville, M.-P. (September 2004). Discovery of new rheumatoid arthritis biomarkers using SELDI-TOF-MS ProteinChip approach. Arthritis and Rheumatism, 50 (9, Suppl. S), 124.

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (May 2001). Association between lipoprotein (A) and cardiac troponins in PTCA patients [Poster presentation]. 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, Czechia.

Chapelle, J.-P., Legrand, V., Lutteri, L., & Gielen, J. (2001). Cardiac troponin I and T concentrations are related to plasma lipoprotein (a) levels in PTCA patients. European Heart Journal, 22, 209.

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Relationship between lipoprotein (a) and cardiac troponins in PTCA patients. Acta Clinica Belgica, 56, 325.

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Association between lipoprotein (A) and cardiac troponins in PTCA patients. Clinical Chemistry and Laboratory Medicine, 39 (suppl), 278.

Lutteri, L., Chapelle, J.-P., Legrand, V., & Gielen, J. (22 January 2000). Hyperhomocysteinemia and cardiovascular risk in PTCA patients [Poster presentation]. Congrès Orbita 2000, Genval, Belgium.

Chapelle, J.-P., Lutteri, L., Legrand, V., & Gielen, J. (June 1999). Determination of total homocysteine in plasma by automated fluorescence polarization immunoassay [Poster presentation]. 17th International and 13th European Congress of Clinical Chemistry and Laboratory Medicine, Firenze, Italy.

Lutteri, L., Chapelle, J.-P., & Gielen, J.-L. (June 1999). Homocysteine et risque cardio-vasculaire. Revue Médicale de Liège, 54 (6), 541-7.

Chapelle, J.-P., Gielen, J., Legrand, V., & Lutteri, L. (1999). Determination of total homocysteine in plasma by automated fluorescence polarization immunoassay. Clinical Chemistry and Laboratory Medicine, 37 (suppl), 373.

Chapelle, J.-P., Lutteri, L., & Gielen, J. (1999). Evaluation of the homocysteine assay on the Abbott IMx. Clinical Chemistry, 45 (6), 134.

Lutteri, L., Chapelle, J.-P., & Gielen, J. (1999). An association demonstrated between homocysteine, CRP and troponin levels in PTCA patients. Acta Clinica Belgica. Supplementum, (suppl.1), 15.